| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 04/21/1999 | EP0909816A1 Anti-fas antibodies |
| 04/21/1999 | EP0909814A2 Use of protein kinases for the diagnosis and treatment of Alzheimer's disease |
| 04/21/1999 | EP0909765A2 Calcitonin analogues having increased hypocalcaemic activity in vivo |
| 04/21/1999 | EP0909564A1 Erythropoietin solution preparation |
| 04/21/1999 | EP0909322A1 Antiviral ricin-like proteins |
| 04/21/1999 | EP0909320A1 CHEMOKINE beta-15 |
| 04/21/1999 | EP0909318A1 Human stem cell antigens, dna coding therefor and their use |
| 04/21/1999 | EP0909317A1 Composition and methods for modulating the length of telomeres |
| 04/21/1999 | EP0909316A1 Glial cell line-derived neurotrophic factor receptor |
| 04/21/1999 | EP0909315A2 Cck-2, a receptor tyrosine kinase |
| 04/21/1999 | EP0909277A2 Humanized antibodies that bind to the same antigen as bound by antibody nr-lu-13, and their use in pretargeting methods |
| 04/21/1999 | EP0909274A1 Methods for purification and use of erythropoietin binding protein |
| 04/21/1999 | EP0909273A1 A transcription factor |
| 04/21/1999 | EP0909181A1 Novel compounds |
| 04/21/1999 | EP0909180A1 Novel compounds |
| 04/21/1999 | EP0909178A1 Interleukin-8 as an antiviral and antitumor agent |
| 04/21/1999 | EP0909177A1 Aqueous formulations of peptides |
| 04/21/1999 | EP0909175A1 Non-aqueous protic peptide formulations |
| 04/21/1999 | EP0909174A1 TREATMENT OF CYSTIC DISEASE WITH TNF-$g(a) |
| 04/21/1999 | EP0765338B1 Arginine mimic derivatives as enzyme inhibitors |
| 04/21/1999 | EP0717731B1 Difluoro statone antiviral analogs |
| 04/21/1999 | EP0695184B1 Hiv protease inhibitors |
| 04/21/1999 | EP0692981B1 Chelators of type xn 1?s 1?x' for radioactive isotopes, their metal complexes and their diagnostic and therapeutical uses |
| 04/21/1999 | EP0692980B1 Type s3n2 chelators for radioactive isotopes, their metal complexes and their diagnostic and therapeutical use |
| 04/21/1999 | EP0674660B1 Multifunctional neurotrophic factors |
| 04/21/1999 | EP0667783B1 Compositions and methods for preventing adhesion formation |
| 04/21/1999 | EP0664834B1 Recombinant humanized anti-cytomegalovirus antibodies |
| 04/21/1999 | EP0640131B1 Genetically engineered antibodies |
| 04/21/1999 | EP0609280B1 Human il-3 variants |
| 04/21/1999 | CN1214734A SCF analog compositions and method |
| 04/21/1999 | CN1214733A Down-regualtion resistant C3 convertase |
| 04/21/1999 | CN1214695A ErdB3 antibodies |
| 04/21/1999 | CN1214694A Peptides with antiproliferative properties |
| 04/21/1999 | CN1214690A Specific immunophilin ligands as antiasthmatics and immunosuppressants |
| 04/21/1999 | CN1214689A Method of producing IGF-I and IGFBP-3 with correct folding and disulfide bonding |
| 04/21/1999 | CN1214682A Eprosartan dihydrate and process for its production and formulation |
| 04/21/1999 | CN1214633A Stabilised growth hormone formulation and method of preparation thereof |
| 04/21/1999 | CN1214632A Remedies or preventives for AIDS |
| 04/21/1999 | CN1214624A Improved tissue destruction in cryosurgery by use of thermal hysteresis proteins |
| 04/21/1999 | CA2248169A1 Dnag |
| 04/20/1999 | US5895810 Stable polymerized hemoglobin and use thereof |
| 04/20/1999 | US5895755 Platelet derived growth factor |
| 04/20/1999 | US5895653 Sterile iron(iii) hydroxide; water in oil emulsion; antigens, immunogens; adsorbed interleukin, cytokine and/or interferon |
| 04/20/1999 | US5895652 Method of metabolic adjuvanation and cellular repair |
| 04/20/1999 | US5895649 Method for treating neurogenic red skin blotches with compositions containing TNF-alpha antagonists |
| 04/20/1999 | US5895647 Use of oral interleukin-6 as therapy for hemorrhagic shock |
| 04/20/1999 | US5895646 Having specific activity in the human bone marrow assay |
| 04/20/1999 | CA2250664A1 Substituted isoquinoline-3-carboxamides, their preparation and their use as pharmaceuticals |
| 04/20/1999 | CA2133649C Oral infection of insect larvae with pre-occluded baculovirus particles |
| 04/20/1999 | CA2120290C Process for preparing spherules of active agents |
| 04/20/1999 | CA1340505C Bovine placental lactogen |
| 04/15/1999 | WO1999018235A1 Process for detecting, extracting or removing human or mammalian cells with a disturbed cellular cycle regulation or unlimited proliferation or tumour-forming ability |
| 04/15/1999 | WO1999018219A1 A keratinocyte derived protease |
| 04/15/1999 | WO1999018216A2 Chimeric vaccine against tick-borne encephalitis virus |
| 04/15/1999 | WO1999018214A1 Porcine circoviruses, vaccines and diagnostic reagents |
| 04/15/1999 | WO1999018213A1 MUTANTS OF YEAST Cdc24p, DEFECTIVE IN BINDING OF THE G-PROTEIN BETA SUBUNIT |
| 04/15/1999 | WO1999018212A1 Natural human antibody |
| 04/15/1999 | WO1999018208A1 101 human secreted proteins |
| 04/15/1999 | WO1999018207A1 Human hox c10 and polynucleotides encoding |
| 04/15/1999 | WO1999018206A2 Human cancer antigen ny eso-1/cag-3 and gene encoding same |
| 04/15/1999 | WO1999018205A1 POLYPEPTIDE, cDNA ENCODING THE SAME, AND USE OF THEM |
| 04/15/1999 | WO1999018198A1 Hepatitis c receptor protein cd81 |
| 04/15/1999 | WO1999018197A2 Nucleic acid molecule encoding a (poly)peptide co-segregating in mutated form with autoimmune polyendocrinopathy candidiasis ectodermal dystrophy (apeced) |
| 04/15/1999 | WO1999018193A1 Jnk3 modulators and methods of use |
| 04/15/1999 | WO1999018187A1 NOVEL clpL |
| 04/15/1999 | WO1999018142A1 BIODEGRADABLE LOW MOLECULAR WEIGHT TRIBLOCK POLY(LACTIDE-co-GLYCOLIDE) POLYETHYLENE GLYCOL COPOLYMERS HAVING REVERSE THERMAL GELATION PROPERTIES |
| 04/15/1999 | WO1999018129A1 Soluble single-chain t-cell receptor proteins |
| 04/15/1999 | WO1999018128A1 Fibroblast growth factor with hepatocyte proliferation activity |
| 04/15/1999 | WO1999018127A1 Secreted proteins and polynucleotides encoding them |
| 04/15/1999 | WO1999018126A1 POLYPEPTIDE, cDNA ENCODING THE POLYPEPTIDE, AND USE OF THE BOTH |
| 04/15/1999 | WO1999018125A1 Human facilitative glucose transport protein glut8 |
| 04/15/1999 | WO1999018123A1 Use of neuronal and lymphocytic potassium canal inhibitors for treating neurological diseases of immune origin |
| 04/15/1999 | WO1999018122A1 Ama |
| 04/15/1999 | WO1999018121A1 Method for the covalent attachment of polysaccharides to protein molecules |
| 04/15/1999 | WO1999018120A1 Deuterated cyclosporine analogs and their use as immunomodulating agents |
| 04/15/1999 | WO1999018119A1 Process for freeze-drying proteins |
| 04/15/1999 | WO1999018117A1 3-hydroxyacyl-coa dehydrogenase from staphylococcus aureus |
| 04/15/1999 | WO1999017806A1 Conjugates of galactose-binding lectins and clostridial neurotoxins as analgesics |
| 04/15/1999 | WO1999017802A1 Methods and compositions for the selective modification of nucleic acids |
| 04/15/1999 | WO1999017801A2 Materials and methods relating to the stimulation of cells |
| 04/15/1999 | WO1999017800A1 Secretory leukocyte protease inhibitor dry powder pharmaceutical compositions |
| 04/15/1999 | WO1999017799A1 Cytoplasmic dipeptidylpeptidase iv from human t-cells |
| 04/15/1999 | WO1999017798A1 Methods for the modulation of neovascularization and/or the growth of collateral arteries and/or other arteries from preexisting arteriolar connections |
| 04/15/1999 | WO1999017797A1 Use of growth differenciation factor-9 (gdf-9) as a contraceptive |
| 04/15/1999 | WO1999017796A2 Modulation of lerk-2-mediated cell adhesion |
| 04/15/1999 | WO1999017795A1 RIBOSOME RECYCLING FACTOR (FRR) OF $i(STAPHYLOCOCCUS AUREUS) |
| 04/15/1999 | WO1999017794A1 UDP-N-ACETYLMURAMOYL-L-AIANINE:D-GLUTAMATE LIGASE (murD) OF STAPHYLOCOCCUS AUREUS |
| 04/15/1999 | WO1999017793A1 Hydrochlorides of vancomycin antibiotics and process for producing the same |
| 04/15/1999 | WO1999017792A1 Methods and compositions for treating rheumatoid arthritis |
| 04/15/1999 | WO1999017791A1 Methods and compositions for reducing bacterial tolerance of disinfectants and organic solvents |
| 04/15/1999 | WO1999017790A1 PEPTIDE-CONTAINING α-KETOAMIDE CYSTEINE AND SERINE PROTEASE INHIBITORS |
| 04/15/1999 | WO1999017786A1 Mammalian-derived peptides for the treatment of microbial infection |
| 04/15/1999 | WO1999017785A1 Reptilian-derived peptides for the treatment of microbial infection |
| 04/15/1999 | WO1999017778A1 α-KETOAMIDE MULTICATALYTIC PROTEASE INHIBITORS |
| 04/15/1999 | WO1999017759A2 Methods of modulating serine/threonine protein kinase function with 5-azaquinoxaline-based compounds |
| 04/15/1999 | WO1999017757A1 USE OF P-GLYCOPROTEIN (Pgp) INHIBITORS IN THE TREATMENT OF CANCER |
| 04/15/1999 | WO1999017742A2 Taste masked formulations |
| 04/15/1999 | WO1999017741A1 Chlamydia protein, gene sequence and uses thereof |
| 04/15/1999 | WO1999017740A1 Peptide/lipid complex formation by co-lyophilization |
| 04/15/1999 | WO1999017715A1 Extracellular matrix production promoter |